172 results on '"Do, Hongdo"'
Search Results
2. Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA
3. Publisher Correction: A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
4. Supplementary Methods, Figures 1-5 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
5. Supplementary Highlighted Methods from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
6. Supplementary Tables 1-7 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
7. Somatic GNAQ mutation in the forme fruste of Sturge-Weber syndrome
8. The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
9. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
10. Somatic GNAQ mutation in the forme fruste of Sturge-Weber syndrome
11. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma
12. The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma
13. Donor-Specific Cell-Free DNA as an Emerging Biomarker of Organ Rejection after Liver Transplantation
14. Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non–Small Cell Lung Cancer
15. De novo activating epidermal growth factor mutations (EGFR) in small‐cell lung cancer
16. Characterization of a Novel Tumorigenic Esophageal Adenocarcinoma Cell Line: OANC1
17. Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
18. A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification
19. Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome
20. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
21. EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma
22. A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma
23. Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
24. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer
25. Abstract 823: A case-control study of constitutionalBRCA1methylation in a mammographically screened cohort
26. Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease
27. Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer
28. Limited copy number - high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies
29. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies
30. Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting
31. Adapting an Established Clinical Chemistry Quality Control Measure for Droplet Generation Performance in Digital PCR
32. NTRK and ALK rearrangements in mesothelioma and lung carcinoid.
33. In Reply to Leone
34. Sensitive quantitative detection of somatic mosaic mutation in “double cortex” syndrome
35. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly
36. Interlaboratory Reproducibility of Droplet Digital Polymerase Chain Reaction Using a New DNA Reference Material Format
37. Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase
38. Probe-Free Digital PCR Quantitative Methodology to Measure Donor-Specific Cell-Free DNA after Solid-Organ Transplantation
39. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly
40. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non–small cell lung cancer
41. Interlaboratory Reproducibility of Droplet Digital Polymerase Chain Reaction Using a New DNA Reference Material Format
42. Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment
43. Comparison of 3 Methodologies for Genotyping of Small Deletion and Insertion Polymorphisms
44. Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
45. Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
46. Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome
47. Abstract 383: Is loss of MGMT a therapeutic target in lung cancer
48. Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine
49. Loss ofCDKN2Aexpression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
50. Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.